
Get the Scoop: Fate Therapeutics Dishes Out Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Unlocking the Future with Stem Cell Therapy Fate Therapeutics Grants RSUs to New Employees San Diego, Oct. 02, 2024 – Fate Therapeutics, Inc., a cutting-edge biopharmaceutical company specializing in induced pluripotent stem cell (iPSC)-derived cellular immunotherapies, made a significant announcement on October 1, 2024. The company bestowed restricted stock units (RSUs) totaling 16,400 shares of…